Introduksjon
Denne siden gir en grundig analyse av den kjente historikken for insidernes handelsaktiviteter for Daniel M Junius. Insidere er ledere, direktører eller betydelige investorer i et selskap. Det er ulovlig for insidere å gjøre handler i deres selskaper basert på spesifikke, ikke-offentlig informasjon. Dette betyr ikke at det er ulovlig for dem å gjøre noen handler i deres egne selskaper. Imidlertid må de rapportere alle handler til SEC via et skjema 4. Til tross for disse begrensningene, antyder akademisk forskning at insidere - generelt sett - har en tendens til å overgå markedet i sine egne selskaper.
Gjennomsnittlig handelslønnsomhet
Den gjennomsnittlige handelslønnsomheten er den gjennomsnittlige avkastningen av alle åpne markedskjøp gjort av insideren de siste tre årene. For å beregne dette, undersøker vi hvert eneste åpne marked, uplanlagte kjøp som er gjort av insideren, men dette inkluderer ikke alle handler som ble markert som en del av en 10b5-1 handelsplan. Vi beregner deretter gjennomsnittlig ytelse av disse handlene over 3, 6 og 12 måneder, gjennomsnittlig hver av disse varighetene for å generere en endelig ytelsesmåling for hver handel. Til slutt,
Dersom lønnsomheten for denne interne handelen er "N/A", har enten den interne personen ikke gjort noen åpen-markeds kjøp de siste tre årene, eller så er handlene for nylig til å beregne en pålitelig prestasjonsmåler.
Oppdateringsfrekvens: Daglig
Selskaper med rapporterte insiderposisjoner
SEC-arkiveringene indikerer at Daniel M Junius har rapporterte beholdninger av handler i følgende selskaper:
Verdipapir | Navn | Siste rapporterte høydepunkter |
---|---|---|
US:IDXX / IDEXX Laboratories, Inc. | Director | 3 304 |
US:GLYC / GlycoMimetics, Inc. | Director | 98 459 |
US:IMGN / ImmunoGen, Inc. | Director | 113 518 |
US:VTAE / Vitae Pharmaceuticals, Inc. | Director | 0 |
Hvordan tolke diagrammene
De følgende diagrammene viser aksjens ytelse etter hver åpen markedstransaksjon som ikke var planlagt, utført av Daniel M Junius. Ikke-planlagte handler er handler som ikke ble gjort som en del av en 10b5-1 handelsplan. Aksjeytelsen er kartlagt som kumulativ prosentendring i aksjekursen. For eksempel, hvis en innsidehandel ble gjort 1. januar 2019, vil diagrammet vise daglig prosentendring for verdipapiret til dagens dato. Dersom aksjeprisen går fra $10 til $15 i løpet av denne tiden, vil den kumulative prosentendringen i aksjeprisen være 50%. En endring i prisen fra $10 til $20 vil være 100%, og en endring i prisen fra $10 til $5 vil være - 50%.
Til syvende og sist er målet vårt å avgjøre hvor tett insidernes handler korrelerer med overavkastninger (positiv eller negativ) i aksjekursen for å se om insidere timer sine handler for å tjene på intern informasjon. Se for deg en situasjon der en insider gjør dette. I denne situasjonen, forventer vi enten (a) positive avkastninger etter kjøp, eller (b) negative avkastninger etter salg. I tilfelle (a) KJØP-diagrammet ville vise en serie av oppadgående kurver, som indikerer positive avkastninger etter hver kjøpstransaksjon. I tilfelle (b) ville SALG-diagrammet vise en serie av nedadgående kurver, som indikerer negative avkastninger etter hver salgstransaksjon.
Imidlertid er dette alene ikke nok til å dra konklusjoner. Hvis, for eksempel, aksjeprisen for selskapet steg jevnt over mange år uten å følge en syklisk trend, ville vi forventet at alle postkjøpsdiagrammer skal ha en stigende trend. På samme måte vil ikke-sykliske nedganger over mange år resultere i nedadgående trend i post-trade diagrammer. Ingen av disse diagrammene ville antyde aktiviteter som insidertrening.
Den sterkeste indikatoren ville vært en situasjon der aksjekursen var ekstremt syklisk, og det var både positive signaler i KJØPSdiagrammet og negative plot i SALGSdiagrammet. Denne situasjonen ville vært sterkt antydende om en insider som timet handler til sin økonomiske fordel.
Innsidernes handelshistorikk
Tabellen viser den komplette listen over innsidehandler gjort av Daniel M Junius som avslørt til Securies Exchange Comission (SEC).
Fildato | Transaksjonsdato | Skjema | Ticker | Verdipapir | Kode | Aksjer | Gjenværende aksjer | Prosent endring |
Aksje pris |
Transaksjons verdi |
Gjenværende verdi |
|
---|---|---|---|---|---|---|---|---|---|---|---|---|
2025-05-14 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
S - Sale | −2 683 | 3 304 | −44,81 | 506,41 | −1 358 697 | 1 673 178 | |
2025-05-14 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
M - Exercise | 1 279 | 5 987 | 27,17 | 283,59 | 362 712 | 1 697 853 | |
2025-05-14 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
M - Exercise | 1 404 | 4 708 | 42,49 | 245,79 | 345 089 | 1 157 179 | |
2025-05-08 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
M - Exercise | 262 | 3 304 | 8,61 | ||||
2024-04-02 |
|
4 | GLYC |
GLYCOMIMETICS INC
Common Stock |
A - Award | 5 209 | 98 459 | 5,59 | 3,00 | 15 627 | 295 377 | |
2024-02-01 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
A - Award | 14 | 3 042 | 0,46 | 521,03 | 7 294 | 1 584 973 | |
2023-11-01 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
A - Award | 19 | 3 028 | 0,63 | 396,39 | 7 531 | 1 200 269 | |
2023-08-01 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
A - Award | 14 | 3 009 | 0,47 | 552,78 | 7 739 | 1 663 315 | |
2023-05-11 |
|
4 | GLYC |
GLYCOMIMETICS INC
Common Stock |
P - Purchase | 30 000 | 93 250 | 47,43 | 1,56 | 46 800 | 145 470 | |
2023-05-02 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
A - Award | 13 | 2 995 | 0,44 | 492,16 | 6 398 | 1 474 019 | |
2023-02-17 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
S - Sale | −2 187 | 2 982 | −42,31 | 511,68 | −1 119 044 | 1 525 829 | |
2023-02-17 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
M - Exercise | 2 187 | 5 169 | 73,34 | 206,62 | 451 878 | 1 068 019 | |
2023-02-01 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
A - Award | 14 | 2 982 | 0,47 | 482,95 | 6 761 | 1 440 157 | |
2022-12-07 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
S - Sale | −3 046 | 2 968 | −50,65 | 424,91 | −1 294 276 | 1 261 133 | |
2022-12-07 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
M - Exercise | 3 046 | 6 014 | 102,63 | 160,28 | 488 213 | 963 924 | |
2022-11-18 |
|
4 | GLYC |
GLYCOMIMETICS INC
Common Stock |
P - Purchase | 20 000 | 63 250 | 46,24 | 1,87 | 37 400 | 118 278 | |
2022-11-01 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
A - Award | 18 | 2 968 | 0,61 | 364,28 | 6 557 | 1 081 183 | |
2022-08-02 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
A - Award | 16 | 2 950 | 0,55 | 399,18 | 6 387 | 1 177 581 | |
2022-05-20 |
|
4 | GLYC |
GLYCOMIMETICS INC
Stock Option (right to buy) |
A - Award | 21 000 | 21 000 | |||||
2022-05-13 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Non-Qualified Stock Option (right-to-buy) |
A - Award | 945 | 945 | |||||
2022-05-13 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Deferred Stock Unit |
A - Award | 344 | 344 | |||||
2022-05-03 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
A - Award | 15 | 2 934 | 0,51 | 430,48 | 6 457 | 1 263 028 | |
2022-02-01 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
A - Award | 13 | 2 919 | 0,45 | 489,05 | 6 358 | 1 427 537 | |
2021-11-02 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
A - Award | 10 | 2 906 | 0,35 | 666,14 | 6 661 | 1 935 803 | |
2021-08-12 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Non-Qualified Stock Option (right-to-buy) |
M - Exercise | −2 402 | 0 | −100,00 | ||||
2021-08-12 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
S - Sale | −2 402 | 2 896 | −45,34 | 679,58 | −1 632 355 | 1 968 069 | |
2021-08-12 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
M - Exercise | 2 402 | 5 298 | 82,94 | 85,00 | 204 170 | 450 330 | |
2021-08-03 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
A - Award | 10 | 2 896 | 0,35 | 678,53 | 6 785 | 1 965 023 | |
2021-05-27 |
|
4 | GLYC |
GLYCOMIMETICS INC
Stock Option (right to buy) |
A - Award | 10 500 | 10 500 | |||||
2021-05-27 |
|
4 | GLYC |
GLYCOMIMETICS INC
Common Stock |
A - Award | 5 250 | 43 250 | 13,82 | ||||
2021-05-24 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Non-Qualified Stock Option (right-to-buy) |
M - Exercise | −2 500 | 2 402 | −51,00 | ||||
2021-05-24 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
S - Sale | −2 500 | 2 886 | −46,42 | 539,57 | −1 348 918 | 1 557 191 | |
2021-05-24 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
M - Exercise | 2 500 | 5 386 | 86,63 | 85,00 | 212 500 | 457 810 | |
2021-05-14 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Non-Qualified Stock Option (right-to-buy) |
A - Award | 723 | 723 | |||||
2021-05-14 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Deferred Stock Unit |
A - Award | 224 | 3 387 | 7,08 | ||||
2021-05-04 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
A - Award | 11 | 2 886 | 0,38 | 548,99 | 6 039 | 1 584 385 | |
2021-02-24 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Non-Qualified Stock Option (right-to-buy) |
M - Exercise | −1 000 | 4 902 | −16,94 | ||||
2021-02-24 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Incentive Stock Option (right-to-buy) |
M - Exercise | −898 | 0 | −100,00 | ||||
2021-02-24 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
S - Sale | −1 888 | 2 875 | −39,64 | 538,57 | −1 016 815 | 1 548 381 | |
2021-02-24 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
S - Sale | −10 | 4 763 | −0,21 | 539,19 | −5 392 | 2 568 162 | |
2021-02-24 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
M - Exercise | 1 000 | 4 773 | 26,50 | 85,00 | 85 000 | 405 705 | |
2021-02-24 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
M - Exercise | 898 | 3 773 | 31,23 | 79,54 | 71 427 | 300 104 | |
2021-02-03 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
A - Award | 13 | 2 875 | 0,45 | 478,68 | 6 223 | 1 376 205 | |
2020-11-02 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
A - Award | 15 | 2 862 | 0,53 | 424,82 | 6 372 | 1 215 835 | |
2020-08-21 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Non-Qualified Stock Option (right-to-buy) |
M - Exercise | −3 722 | 0 | −100,00 | ||||
2020-08-21 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
S - Sale | −3 722 | 2 847 | −56,66 | 382,61 | −1 424 063 | 1 089 282 | |
2020-08-21 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
M - Exercise | 3 722 | 6 569 | 130,73 | 63,95 | 238 022 | 420 088 | |
2020-08-03 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
A - Award | 13 | 2 847 | 0,46 | 371,10 | 4 824 | 1 056 522 | |
2020-05-27 |
|
4 | GLYC |
GLYCOMIMETICS INC
Stock Option (right to buy) |
A - Award | 21 000 | 21 000 | |||||
2020-05-20 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Non-Qualified Stock Option (right-to-buy) |
M - Exercise | −4 000 | 3 422 | −53,89 | ||||
2020-05-20 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
S - Sale | 4 000 | 2 834 | −343,05 | 295,61 | 1 182 433 | 837 754 | |
2020-05-20 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
M - Exercise | 4 000 | 6 834 | 141,14 | 63,95 | 255 800 | 437 034 | |
2020-05-08 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Non-Qualified Stock Option (right-to-buy) |
A - Award | 1 279 | 1 279 | |||||
2020-05-08 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Deferred Stock Unit |
A - Award | 370 | 3 163 | 13,25 | ||||
2020-03-10 |
|
4 | GLYC |
GLYCOMIMETICS INC
Common Stock |
P - Purchase | 20 000 | 38 000 | 111,11 | 3,40 | 68 000 | 129 200 | |
2020-02-03 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
A - Award | 22 | 2 834 | 0,78 | 283,73 | 6 242 | 804 091 | |
2019-10-31 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
A - Award | 23 | 2 812 | 0,82 | 273,85 | 6 299 | 770 066 | |
2019-08-15 |
|
4 | GLYC |
GLYCOMIMETICS INC
Common Stock |
P - Purchase | 10 000 | 18 000 | 125,00 | 3,18 | 31 800 | 57 240 | |
2019-08-01 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
A - Award | 22 | 2 789 | 0,80 | 286,05 | 6 293 | 797 793 | |
2019-05-21 |
|
4 | GLYC |
GLYCOMIMETICS INC
Stock Option (right to buy) |
A - Award | 21 000 | 21 000 | |||||
2019-05-10 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Non-Qualified Stock Option (right-to-buy) |
A - Award | 1 404 | 1 404 | |||||
2019-05-10 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Deferred Stock Unit |
A - Award | 427 | 2 793 | 18,05 | ||||
2019-05-02 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
A - Award | 26 | 2 767 | 0,95 | 232,00 | 6 032 | 641 944 | |
2019-02-01 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
A - Award | 29 | 2 741 | 1,07 | 207,68 | 6 023 | 569 251 | |
2018-11-01 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
A - Award | 28 | 2 712 | 1,04 | 210,22 | 5 886 | 570 117 | |
2018-08-01 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
A - Award | 25 | 2 684 | 0,94 | 237,76 | 5 944 | 638 148 | |
2018-05-21 |
|
4 | GLYC |
GLYCOMIMETICS INC
Stock Option (right to buy) |
A - Award | 11 000 | 11 000 | |||||
2018-05-11 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Non-Qualified Stock Option (right-to-buy) |
A - Award | 2 187 | 2 187 | |||||
2018-05-11 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Deferred Stock Unit |
A - Award | 224 | 2 366 | 10,46 | ||||
2018-05-02 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
A - Award | 31 | 2 659 | 1,18 | 194,49 | 6 029 | 517 149 | |
2018-03-16 |
|
4 | IMGN |
IMMUNOGEN INC
Stock Option (right to buy) |
M - Exercise | −25 000 | 113 518 | −18,05 | 4,29 | −107 250 | 486 992 | |
2018-03-16 |
|
4 | IMGN |
IMMUNOGEN INC
Common Stock |
S - Sale | −25 000 | 184 987 | −11,91 | 12,02 | −300 405 | 2 222 841 | |
2018-03-16 |
|
4 | IMGN |
IMMUNOGEN INC
Common Stock |
M - Exercise | 25 000 | 209 987 | 13,51 | 4,29 | 107 250 | 900 844 | |
2018-03-02 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Non-Qualified Stock Option (right-to-buy) |
M - Exercise | −2 974 | 0 | −100,00 | ||||
2018-03-02 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
S - Sale | −2 974 | 2 628 | −53,09 | 190,06 | −565 232 | 499 472 | |
2018-03-02 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
M - Exercise | 2 974 | 5 602 | 113,17 | 64,69 | 192 388 | 362 393 | |
2018-02-23 |
|
4 | IMGN |
IMMUNOGEN INC
Common Stock |
S - Sale | −11 713 | 184 987 | −5,95 | 12,00 | −140 556 | 2 219 844 | |
2018-02-21 |
|
4 | IMGN |
IMMUNOGEN INC
Common Stock |
S - Sale | −25 000 | 196 700 | −11,28 | 11,68 | −292 000 | 2 297 456 | |
2018-02-20 |
|
4 | IMGN |
IMMUNOGEN INC
Stock Option (right to buy) |
M - Exercise | −25 000 | 163 518 | −13,26 | 4,29 | −107 250 | 701 492 | |
2018-02-20 |
|
4 | IMGN |
IMMUNOGEN INC
Common Stock |
M - Exercise | 25 000 | 221 700 | 12,71 | 4,29 | 107 250 | 951 093 | |
2018-02-14 |
|
4 | IMGN |
IMMUNOGEN INC
Stock Option (right to buy) |
M - Exercise | −46 667 | 0 | −100,00 | 3,30 | −154 001 | ||
2018-02-14 |
|
4 | IMGN |
IMMUNOGEN INC
Common Stock |
S - Sale | −46 667 | 196 700 | −19,18 | 10,01 | −467 253 | 1 969 459 | |
2018-02-14 |
|
4 | IMGN |
IMMUNOGEN INC
Common Stock |
M - Exercise | 46 667 | 243 367 | 23,72 | 3,30 | 154 001 | 803 111 | |
2018-02-01 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
A - Award | 32 | 2 628 | 1,23 | 186,59 | 5 971 | 490 359 | |
2017-11-01 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
A - Award | 36 | 2 596 | 1,41 | 164,41 | 5 919 | 426 808 | |
2017-07-31 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
A - Award | 35 | 2 560 | 1,39 | 167,52 | 5 863 | 428 851 | |
2017-06-16 |
|
4 | GLYC |
GLYCOMIMETICS INC
Common Stock |
A - Award | 3 000 | 8 000 | 60,00 | 11,27 | 33 810 | 90 160 | |
2017-06-15 |
|
4 | IMGN |
IMMUNOGEN INC
Stock Option (right to buy) |
A - Award | 10 000 | 10 000 | 4,64 | 46 400 | 46 400 | ||
2017-06-15 |
|
4 | IMGN |
IMMUNOGEN INC
Deferred Share Unit |
A - Award | 3 000 | 4 500 | 200,00 | ||||
2017-05-30 |
|
4 | GLYC |
GLYCOMIMETICS INC
Stock Option (right to buy) |
A - Award | 11 000 | 11 000 | |||||
2017-05-05 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Non-Qualified Stock Option (right-to-buy) |
A - Award | 3 046 | 3 046 | |||||
2017-05-05 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Deferred Stock Unit |
A - Award | 289 | 2 142 | 15,60 | ||||
2017-05-01 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
A - Award | 30 | 2 525 | 1,20 | 167,73 | 5 032 | 423 518 | |
2017-02-09 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Non-Qualified Stock Option (right-to-buy) |
M - Exercise | −3 000 | 2 964 | −50,30 | ||||
2017-02-09 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
S - Sale | −3 000 | 2 495 | −54,60 | 141,75 | −425 264 | 353 677 | |
2017-02-09 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
M - Exercise | 3 000 | 5 495 | 120,24 | 64,69 | 194 070 | 355 472 | |
2017-01-31 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
A - Award | 41 | 2 495 | 1,67 | 120,50 | 4 940 | 300 648 | |
2016-12-21 |
|
4 | GLYC |
GLYCOMIMETICS INC
Common Stock |
P - Purchase | 5 000 | 5 000 | 6,01 | 30 050 | 30 050 | ||
2016-12-13 |
|
4 | IMGN |
IMMUNOGEN INC
Stock Option (right to buy) |
A - Award | 5 000 | 5 000 | 1,84 | 9 200 | 9 200 | ||
2016-12-13 |
|
4 | IMGN |
IMMUNOGEN INC
Deferred Share Unit |
A - Award | 1 500 | 1 500 | |||||
2016-10-31 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
A - Award | 48 | 2 454 | 2,00 | 105,05 | 5 042 | 257 793 | |
2016-10-25 |
|
4 | VTAE |
Vitae Pharmaceuticals, Inc
Stock Option (Right to Buy) |
D - Sale to Issuer | −20 000 | 0 | −100,00 | 9,63 | −192 600 | ||
2016-08-02 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
A - Award | 53 | 2 406 | 2,25 | 93,79 | 4 971 | 225 659 | |
2016-07-27 |
|
4 | VTAE |
Vitae Pharmaceuticals, Inc
Stock Option (Right to Buy) |
A - Award | 20 000 | 20 000 | |||||
2016-06-02 |
|
4 | IMGN |
IMMUNOGEN INC
Stock Option (right to buy) |
M - Exercise | −27 085 | 0 | −100,00 | 3,19 | −86 401 | ||
2016-06-02 |
|
4 | IMGN |
IMMUNOGEN INC
Common Stock |
M - Exercise | 27 085 | 196 700 | 15,97 | 3,19 | 86 401 | 627 473 | |
2016-05-19 |
|
4 | GLYC |
GLYCOMIMETICS INC
Stock Option (right to buy) |
A - Award | 11 000 | 11 000 | |||||
2016-05-06 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Non-Qualified Stock Option (right-to-buy) |
A - Award | 5 902 | 5 902 | |||||
2016-05-06 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Deferred Stock Unit |
A - Award | 515 | 1 853 | 38,49 | ||||
2016-05-03 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
A - Award | 59 | 2 353 | 2,57 | 84,35 | 4 977 | 198 476 | |
2016-03-21 |
|
4 | GLYC |
GLYCOMIMETICS INC
Stock Option (right to buy) |
A - Award | 22 000 | 22 000 | |||||
2016-03-21 | 3 | GLYC |
GLYCOMIMETICS INC
No securities beneficially owned |
0 | ||||||||
2016-02-02 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
A - Award | 71 | 2 294 | 3,19 | 70,14 | 4 980 | 160 901 | |
2016-01-04 |
|
4 | IMGN |
IMMUNOGEN INC
Stock Option (right to buy) |
M - Exercise | −5 416 | 27 085 | −16,66 | 3,19 | −17 277 | 86 401 | |
2016-01-04 |
|
4 | IMGN |
IMMUNOGEN INC
Common Stock |
S - Sale | X | −5 416 | 169 615 | −3,09 | 13,17 | −71 349 | 2 234 474 |
2016-01-04 |
|
4 | IMGN |
IMMUNOGEN INC
Common Stock |
M - Exercise | X | 5 416 | 175 031 | 3,19 | 3,19 | 17 277 | 558 349 |
2015-12-21 |
|
4 | IMGN |
IMMUNOGEN INC
Common Stock |
G - Gift | −1 003 | 169 615 | −0,59 | ||||
2015-12-01 |
|
4 | IMGN |
IMMUNOGEN INC
Stock Option (right to buy) |
M - Exercise | −5 416 | 32 501 | −14,28 | 3,19 | −17 277 | 103 678 | |
2015-12-01 |
|
4 | IMGN |
IMMUNOGEN INC
Common Stock |
S - Sale | X | −5 416 | 170 618 | −3,08 | 13,11 | −71 025 | 2 237 467 |
2015-12-01 |
|
4 | IMGN |
IMMUNOGEN INC
Common Stock |
M - Exercise | X | 5 416 | 176 035 | 3,17 | 3,19 | 17 277 | 561 552 |
2015-11-04 |
|
4 | IMGN |
IMMUNOGEN INC
Stock Option (right to buy) |
M - Exercise | −5 907 | 188 518 | −3,04 | 4,29 | −25 341 | 808 742 | |
2015-11-04 |
|
4 | IMGN |
IMMUNOGEN INC
Common Stock |
M - Exercise | 5 907 | 170 618 | 3,59 | 4,29 | 25 341 | 731 951 | |
2015-11-03 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
A - Award | 73 | 2 223 | 3,40 | 68,62 | 5 009 | 152 542 | |
2015-11-03 |
|
4 | IMGN |
IMMUNOGEN INC
Stock Option (right to buy) |
M - Exercise | −5 497 | 37 917 | −12,66 | 3,19 | −17 535 | 120 955 | |
2015-11-03 |
|
4 | IMGN |
IMMUNOGEN INC
Common Stock |
S - Sale | X | −5 497 | 159 812 | −3,33 | 12,00 | −65 964 | 1 917 744 |
2015-11-03 |
|
4 | IMGN |
IMMUNOGEN INC
Common Stock |
M - Exercise | X | 5 497 | 165 309 | 3,44 | 3,19 | 17 535 | 527 336 |
2015-11-03 |
|
4 | IMGN |
IMMUNOGEN INC
Stock Option (right to buy) |
M - Exercise | −122 | 62 669 | −0,19 | 5,77 | −704 | 361 600 | |
2015-11-03 |
|
4 | IMGN |
IMMUNOGEN INC
Stock Option (right to buy) |
M - Exercise | −5 575 | 194 425 | −2,79 | 4,29 | −23 917 | 834 083 | |
2015-11-03 |
|
4 | IMGN |
IMMUNOGEN INC
Common Stock |
M - Exercise | 122 | 159 812 | 0,08 | 5,77 | 704 | 922 115 | |
2015-11-03 |
|
4 | IMGN |
IMMUNOGEN INC
Common Stock |
M - Exercise | 5 575 | 159 690 | 3,62 | 4,29 | 23 917 | 685 070 | |
2015-10-30 |
|
4 | IMGN |
IMMUNOGEN INC
Stock Option (right to buy) |
M - Exercise | −5 335 | 43 414 | −10,94 | 3,19 | −17 019 | 138 491 | |
2015-10-30 |
|
4 | IMGN |
IMMUNOGEN INC
Common Stock |
S - Sale | −5 335 | 154 115 | −3,35 | 12,01 | −64 072 | 1 850 875 | |
2015-10-30 |
|
4 | IMGN |
IMMUNOGEN INC
Common Stock |
M - Exercise | X | 5 335 | 159 450 | 3,46 | 3,19 | 17 019 | 508 646 |
2015-09-09 |
|
4 | IMGN |
IMMUNOGEN INC
Stock Option (right to buy) |
M - Exercise | −4 899 | 62 791 | −7,24 | 5,77 | −28 267 | 362 304 | |
2015-09-09 |
|
4 | IMGN |
IMMUNOGEN INC
Common Stock |
M - Exercise | 4 899 | 159 014 | 3,18 | 5,77 | 28 267 | 917 511 | |
2015-09-01 |
|
4 | IMGN |
IMMUNOGEN INC
Stock Option (right to buy) |
M - Exercise | −5 416 | 48 749 | −10,00 | 3,19 | −17 277 | 155 509 | |
2015-09-01 |
|
4 | IMGN |
IMMUNOGEN INC
Common Stock |
S - Sale | −5 416 | 154 115 | −3,39 | 13,15 | −71 238 | 2 027 121 | |
2015-09-01 |
|
4 | IMGN |
IMMUNOGEN INC
Common Stock |
M - Exercise | X | 5 416 | 159 531 | 3,51 | 3,19 | 17 277 | 508 904 |
2015-08-18 |
|
4 | IMGN |
IMMUNOGEN INC
Stock Option (right to buy) |
M - Exercise | −12 310 | 67 690 | −15,39 | 5,77 | −71 029 | 390 571 | |
2015-08-18 |
|
4 | IMGN |
IMMUNOGEN INC
Common Stock |
M - Exercise | 12 310 | 154 115 | 8,68 | 5,77 | 71 029 | 889 244 | |
2015-08-05 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
P - Purchase | 1 000 | 2 150 | 86,96 | 73,15 | 73 150 | 157 272 | |
2015-08-04 |
|
4 | IMGN |
IMMUNOGEN INC
Stock Option (right to buy) |
M - Exercise | −5 416 | 54 165 | −9,09 | 3,19 | −17 277 | 172 786 | |
2015-08-04 |
|
4 | IMGN |
IMMUNOGEN INC
Common Stock |
S - Sale | −5 416 | 141 805 | −3,68 | 17,03 | −92 247 | 2 415 279 | |
2015-08-04 |
|
4 | IMGN |
IMMUNOGEN INC
Common Stock |
M - Exercise | X | 5 416 | 147 221 | 3,82 | 3,19 | 17 277 | 469 635 |
2015-08-03 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
A - Award | 70 | 1 150 | 6,48 | 71,34 | 4 994 | 82 041 | |
2015-07-14 |
|
4 | IMGN |
IMMUNOGEN INC
Stock option (right to buy) |
A - Award | 205 000 | 205 000 | 16,72 | 3 427 600 | 3 427 600 | ||
2015-07-02 |
|
4 | IMGN |
IMMUNOGEN INC
Stock Option (right to buy) |
M - Exercise | −5 416 | 59 584 | −8,33 | 3,19 | −17 277 | 190 073 | |
2015-07-02 |
|
4 | IMGN |
IMMUNOGEN INC
Common Stock |
S - Sale | −5 416 | 141 805 | −3,68 | 14,34 | −77 676 | 2 033 767 | |
2015-07-02 |
|
4 | IMGN |
IMMUNOGEN INC
Common Stock |
M - Exercise | X | 5 416 | 147 221 | 3,82 | 3,19 | 17 277 | 469 635 |
2015-05-11 |
|
4 | IMGN |
IMMUNOGEN INC
Stock Option (right to buy) |
M - Exercise | −1 215 | 0 | −100,00 | 5,74 | −6 974 | ||
2015-05-11 |
|
4 | IMGN |
IMMUNOGEN INC
Common Stock |
S - Sale | −1 215 | 141 805 | −0,85 | 8,02 | −9 744 | 1 137 276 | |
2015-05-11 |
|
4 | IMGN |
IMMUNOGEN INC
Common Stock |
M - Exercise | 1 215 | 143 020 | 0,86 | 5,74 | 6 974 | 820 935 | |
2015-05-08 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Non-Qualified Stock Option (right to buy) |
A - Award | 3 861 | 3 861 | |||||
2015-05-08 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Deferred Stock Unit |
A - Award | 342 | 669 | 104,59 | ||||
2015-05-05 |
|
4 | IMGN |
IMMUNOGEN INC
Stock Option (right to buy) |
M - Exercise | −10 647 | 1 215 | −89,76 | 5,74 | −61 114 | 6 974 | |
2015-05-05 |
|
4 | IMGN |
IMMUNOGEN INC
Common Stock |
M - Exercise | 10 647 | 141 805 | 8,12 | 5,74 | 61 114 | 813 961 | |
2015-05-05 |
|
4 | IMGN |
IMMUNOGEN INC
Stock Option (right to buy) |
M - Exercise | −35 315 | 11 862 | −74,86 | 5,74 | −202 708 | 68 088 | |
2015-05-05 |
|
4 | IMGN |
IMMUNOGEN INC
Common Stock |
S - Sale | −35 315 | 131 158 | −21,21 | 8,36 | −295 198 | 1 096 350 | |
2015-05-05 |
|
4 | IMGN |
IMMUNOGEN INC
Common Stock |
M - Exercise | X | 35 315 | 166 473 | 26,93 | 5,74 | 202 708 | 955 555 |
2015-05-04 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
A - Award | 40 | 540 | 8,00 | 125,37 | 5 015 | 67 700 | |
2015-04-22 |
|
4 | IMGN |
IMMUNOGEN INC
Stock Option (right to buy) |
M - Exercise | −6 969 | 47 177 | −12,87 | 5,74 | −40 002 | 270 796 | |
2015-04-22 |
|
4 | IMGN |
IMMUNOGEN INC
Common Stock |
M - Exercise | 6 969 | 131 158 | 5,61 | 5,74 | 40 002 | 752 847 | |
2015-04-06 |
|
4 | IMGN |
IMMUNOGEN INC
Stock Option (right to buy) |
M - Exercise | −26 132 | 54 146 | −32,55 | 5,74 | −149 998 | 310 798 | |
2015-04-06 |
|
4 | IMGN |
IMMUNOGEN INC
Common Stock |
M - Exercise | 26 132 | 124 189 | 26,65 | 5,74 | 149 998 | 712 845 | |
2015-02-18 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Non-Qualified Stock Option (right to buy) |
A - Award | 449 | 449 | |||||
2015-02-18 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Deferred Stock Unit |
A - Award | 37 | 327 | 12,76 | ||||
2014-09-22 |
|
4 | IMGN |
IMMUNOGEN INC
Stock Option (right to buy) |
M - Exercise | −17 421 | 76 278 | −18,59 | 5,74 | −99 997 | 437 836 | |
2014-09-22 |
|
4 | IMGN |
IMMUNOGEN INC
Common Stock |
M - Exercise | 17 421 | 98 057 | 21,60 | 5,74 | 99 997 | 562 847 | |
2014-07-18 |
|
4 | IMGN |
IMMUNOGEN INC
Stock option (right to buy) |
A - Award | 205 000 | 205 000 | 10,79 | 2 211 950 | 2 211 950 | ||
2014-05-09 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Non-Qualified Stock Options (right to buy) |
A - Award | 2 987 | 2 987 | |||||
2014-05-09 |
|
4 | IDXX |
IDEXX LABORATORIES INC /DE
Deferred Stock Unit |
A - Award | 290 | 290 | |||||
2014-03-18 |
|
4 | IMGN |
IMMUNOGEN INC
Stock Option (right to buy) |
M - Exercise | −15 000 | 97 699 | −13,31 | 5,74 | −86 100 | 560 792 | |
2014-03-18 |
|
4 | IMGN |
IMMUNOGEN INC
Common Stock |
S - Sale | −15 000 | 80 636 | −15,68 | 16,40 | −246 000 | 1 322 430 | |
2014-03-18 |
|
4 | IMGN |
IMMUNOGEN INC
Common Stock |
M - Exercise | 15 000 | 95 636 | 18,60 | 5,74 | 86 100 | 548 951 | |
2014-03-14 | 3 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
1 000 | ||||||||
2014-03-14 | 3 | IDXX |
IDEXX LABORATORIES INC /DE
Common Stock |
1 000 | ||||||||
2014-02-20 |
|
4 | IMGN |
IMMUNOGEN INC
Stock Option (right to buy) |
M - Exercise | −15 000 | 112 699 | −11,75 | 5,74 | −86 100 | 646 892 | |
2014-02-20 |
|
4 | IMGN |
IMMUNOGEN INC
Common Stock |
S - Sale | −15 000 | 80 636 | −15,68 | 16,26 | −243 922 | 1 311 262 | |
2014-02-20 |
|
4 | IMGN |
IMMUNOGEN INC
Common Stock |
M - Exercise | 15 000 | 95 636 | 18,60 | 5,74 | 86 100 | 548 951 | |
2013-12-27 |
|
4 | IMGN |
IMMUNOGEN INC
Stock Option (right to buy) |
M - Exercise | −7 300 | 127 699 | −5,41 | 5,74 | −41 902 | 732 992 | |
2013-12-27 |
|
4 | IMGN |
IMMUNOGEN INC
Common Stock |
M - Exercise | 7 300 | 80 636 | 9,95 | 5,74 | 41 902 | 462 851 | |
2013-12-12 |
|
4 | IMGN |
IMMUNOGEN INC
Stock Option (right to buy) |
M - Exercise | −15 000 | 134 999 | −10,00 | 5,74 | −86 100 | 774 894 | |
2013-12-12 |
|
4 | IMGN |
IMMUNOGEN INC
Common Stock |
S - Sale | −15 000 | 73 336 | −16,98 | 15,11 | −226 695 | 1 108 327 | |
2013-12-12 |
|
4 | IMGN |
IMMUNOGEN INC
Common Stock |
M - Exercise | 15 000 | 88 336 | 20,45 | 5,74 | 86 100 | 507 049 | |
2013-09-05 |
|
4 | IMGN |
IMMUNOGEN INC
Stock Option (right to buy) |
M - Exercise | −16 667 | 149 999 | −10,00 | 5,74 | −95 669 | 860 994 | |
2013-09-05 |
|
4 | IMGN |
IMMUNOGEN INC
Common Stock |
S - Sale | −16 667 | 73 336 | −18,52 | 16,43 | −273 772 | 1 204 617 | |
2013-09-05 |
|
4 | IMGN |
IMMUNOGEN INC
Common Stock |
M - Exercise | X | 16 667 | 90 003 | 22,73 | 5,74 | 95 669 | 516 617 |
2013-08-02 |
|
4 | IMGN |
IMMUNOGEN INC
Stock Option (right to buy) |
M - Exercise | −16 667 | 166 666 | −9,09 | 5,74 | −95 669 | 956 663 | |
2013-08-02 |
|
4 | IMGN |
IMMUNOGEN INC
Common Stock |
S - Sale | −16 667 | 73 336 | −18,52 | 19,21 | −320 140 | 1 408 638 | |
2013-08-02 |
|
4 | IMGN |
IMMUNOGEN INC
Common Stock |
M - Exercise | X | 16 667 | 90 003 | 22,73 | 5,74 | 95 669 | 516 617 |
2013-07-17 |
|
4 | IMGN |
IMMUNOGEN INC
Stock option (right to buy) |
A - Award | 205 000 | 205 000 | 19,02 | 3 899 100 | 3 899 100 | ||
2013-07-05 |
|
4 | IMGN |
IMMUNOGEN INC
Stock Option (right to buy) |
M - Exercise | −16 667 | 183 333 | −8,33 | 5,74 | −95 669 | 1 052 331 | |
2013-07-05 |
|
4 | IMGN |
IMMUNOGEN INC
Common Stock |
S - Sale | −16 667 | 73 336 | −18,52 | 17,31 | −288 529 | 1 269 549 | |
2013-07-05 |
|
4 | IMGN |
IMMUNOGEN INC
Common Stock |
M - Exercise | X | 16 667 | 90 003 | 22,73 | 5,74 | 95 669 | 516 617 |
2012-07-23 |
|
4 | IMGN |
IMMUNOGEN INC
Stock option (right to buy) |
A - Award | 180 000 | 180 000 | 15,83 | 2 849 400 | 2 849 400 | ||
2008-06-13 |
|
4 | IMGN |
IMMUNOGEN INC
Incentive stock option (right to buy) |
A - Award | 23 333 | 23 333 | 3,30 | 76 999 | 76 999 | ||
2008-06-13 |
|
4 | IMGN |
IMMUNOGEN INC
Non-qualified stock option (right to buy) |
A - Award | 46 667 | 46 667 | 3,30 | 154 001 | 154 001 |